Cargando…
Lipidomics: a promising cancer biomarker
The prevention, diagnosis and targeted therapies of cancer are important in cancer controlling and treatment. The present challenge about cancer biomarker still remains in identifying the special biomarkers for predicting cancer risk and assessing patient’s response during anticancer treatment. Lipi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064713/ https://www.ncbi.nlm.nih.gov/pubmed/30058036 http://dx.doi.org/10.1186/s40169-018-0199-0 |